Early proactive therapeutic drug monitoring program for management of infliximab in inflammatory bowel disease: long-term durability of treatments

被引:0
|
作者
Sanchez-Hernandez, J. G. [1 ]
Rebollo, N. [1 ]
Munoz, F. [2 ]
Saez-Fernandez, E. M. [1 ]
Rodriguez-Rodriguez, G. [1 ]
Tapia-Artiles, C. [1 ]
Fernandez-Caballero, R. [1 ]
Calvo, M. V. [1 ]
机构
[1] Hosp Univ Salamanca, Pharm Serv, Salamanca, Spain
[2] Hosp Clin Univ Salamanca, Gastroenterol Serv, Salamanca, Spain
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
TDMP002
引用
收藏
页码:232 / 233
页数:2
相关论文
共 50 条
  • [21] Therapeutic drug monitoring of infliximab in inflammatory bowel disease versus optimization of treatments based on clinical response
    German Sanchez, Jose
    Rebollo, Noemi
    Munoz, Fernando
    Jose Duque, Juan
    Laso, Esther
    Pilar Garcia, Maria
    Victoria Calvo, Maria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 340 - 340
  • [22] Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab
    Papamichael, Konstantinos
    Chachu, Karen A.
    Vajravelu, Ravy K.
    Vaughn, Byron P.
    Ni, Josephine
    Osterman, Mark T.
    Cheifetz, Adam S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (10) : 1580 - +
  • [23] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    Marzo, M.
    Felice, C.
    Mocci, G.
    De Vincentis, F.
    Andrisani, G.
    Pugliese, D.
    Fedeli, P.
    De Vitis, I.
    Papa, A.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S88 - S88
  • [24] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S12 - S12
  • [25] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, Alessandro
    De pascalis, Barbara
    Roberto, Italia
    Ennas, Sara
    De vincentis, Fabio
    Guglielmo, Simona
    Fedeli, Paolo
    Papa, Alfredo
    De vitis, Italo
    Gasbarrini, Giovanni
    Melina, Domenico
    Fedeli, Giuseppe
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2007, 132 (04) : A183 - A183
  • [26] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2009, 13 : 84 - 84
  • [27] Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease
    Armuzzi, Alessandro
    De Vincentis, Fabio
    Marzo, Manuela
    Mocci, Giammarco
    Felice, Carla
    Fedeli, Paolo
    De Vitis, Italo
    Papa, Alfredo
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2009, 136 (05) : A663 - A663
  • [28] BUDGET IMPACT ANALYSIS OF PROACTIVE THERAPEUTIC DRUG MONITORING FOR INFLAMMATORY BOWEL DISEASE PATIENTS IN THE UNITED STATES ON INFLIXIMAB THERAPY
    Dervieux, T.
    Vasquez, P.
    Shim, A.
    Simbaqueba, E.
    VALUE IN HEALTH, 2023, 26 (06) : S73 - S73
  • [29] PROACTIVE THERAPEUTIC DRUG MONITORING MAY REDUCE THE NEED FOR COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH INFLIXIMAB
    Doherty, Jayne
    Varley, Rachel
    Healy, Martin
    Dunne, Cara
    Maccarthy, Finbar
    Mckiernan, Susan
    Hartery, Karen
    Kevans, David
    GASTROENTEROLOGY, 2022, 162 (07) : S804 - S804
  • [30] Proactive Therapeutic Drug Monitoring May Reduce the Need for Combination Therapy in Inflammatory Bowel Disease Patients Treated with Infliximab
    Doherty, J.
    Varley, R.
    Dunne, C.
    Mc Carthy, F.
    Hartery, K.
    Mc Kiernan, S.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I391 - I391